Congratulations, Maureen Smith!

RareKids-CAN is thrilled to extend our happiest congratulations to Maureen Smith on her new position on the Board of Directors for Canada's Drug Agency (CDA)! Maureen is a patient partner with RareKids-CAN and will be the first-ever Patient Member on the CDA Board of Directors. She also has extensive leadership experiences with other organizations, including co-Principal Investigator and Patient Engagement Strategy lead with INFORM RARE.

From the entire RareKids-CAN team, congratulations Maureen!

You can read more about this on the CDA news page.